PO-1336 Prognosticator of SBRT efficacy and toxicity in early-stage NSCLC patients.

Saved in:
Bibliographic Details
Title: PO-1336 Prognosticator of SBRT efficacy and toxicity in early-stage NSCLC patients.
Authors: Walz, D. (AUTHOR), Salome, P. (AUTHOR), Sforazzini, F. (AUTHOR), Kudak, A. (AUTHOR), Dostal, M. (AUTHOR), Regnery, S. (AUTHOR), Schlamp, K. (AUTHOR), Heußel, C.P. (AUTHOR), Herth, F. (AUTHOR), Thomas, M. (AUTHOR), Hoerner-Rieber, J. (AUTHOR), Debus, J. (AUTHOR), Knoll, M. (AUTHOR), Abdollahi, A. (AUTHOR)
Source: Radiotherapy & Oncology. 2023 Supplement 1, Vol. 182, pS1070-S1071. 2p.
Database: Academic Search Ultimate
Description
ISSN:01678140
DOI:10.1016/S0167-8140(23)66251-6